[AVDL] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AVDL] Avadel Pharmaceuticals plc
Announcement Date
09-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 68.25%
YoY- 8.44%
Quarter Report
AVDL's Result
AVDL's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,496 0 0 0 0 0 0 -
PBT -64,342 -31,364 -27,365 -20,076 -33,251 -30,747 -26,644 80.28%
Tax 90 -580 85 70 30,193 -4,323 -4,343 -
NP -64,432 -30,784 -27,450 -20,146 -63,444 -26,424 -22,301 103.24%
Tax Rate - - - - - - - -
Total Cost 65,928 30,784 27,450 20,146 63,444 26,424 22,301 106.39%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -4,306.95 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.83 -0.48 -0.43 -0.33 -1.07 -0.45 -0.38 68.58%
EPS Diluted -0.83 -0.48 -0.43 -0.33 -1.07 -0.45 -0.38 68.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.